Treatment satisfaction, safety and effectiveness of adding methotrexate to adalimumab in patients with psoriasis responding suboptimally to adalimumab in a real‐world setting-Reference-Cited by-同舟云学术

Treatment satisfaction, safety and effectiveness of adding methotrexate to adalimumab in patients with psoriasis responding suboptimally to adalimumab in a real‐world setting

Published:2022-01-20 Issue: Volume: Page:
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Papp K.A.¹²^ORCID,Gooderham M.J.¹³⁴^ORCID,Albrecht L.E.¹⁵⁶,Raymond M.‐A.⁷^ORCID,Lynde C.W.¹⁸^ORCID

Affiliation:

1. Probity Medical Research Waterloo ONCanada

2. K. Papp Clinical Research Waterloo ONCanada

3. SKiN Centre for Dermatology Peterborough ONCanada

4. Queen’s University Kingston ONCanada

5. Enverus Medical Research Surrey BCCanada

6. Department of Dermatology and Skin Science University of British Columbia Vancouver BCCanada

7. Former employee of AbbVie Corporation Montreal QCCanada

8. University of Toronto Toronto ON Canada

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.20885

Reference7 articles.

1. Efficacy and safety of ustekinumab, a human interleukin‐12/23 monoclonal antibody, in patients with psoriasis: 76‐week results from a randomised, double‐blind, placebo‐controlled trial (PHOENIX 1);Leonardi C;Lancet,2008

2. Adalimumab therapy for moderate to severe psoriasis: a randomized, controlled phase III trial;Menter A;J Am Acad Dermatol,2008

3. Effectiveness and safety of initiating adalimumab plus ≥12 mg/week methotrexate with adjustable dosing in biologic‐naïve patients with early rheumatoid arthritis: HAWK study postmarketing surveillance in Japan;Tanaka Y;Mod Rheumatol,2019

4. Abbvie. A study of subjects with psoriatic arthritis to investigate the effectiveness of adalimumab introduction compared with methotrexate dose escalation (CONTROL). ClinicalTrials.gov identifier: NCT02814175.

5. Canadian guidelines for the management of plaque psoriasis: overview;Papp K;J Cut Med Surg,2011

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research hotspots and trends in biological agents for psoriasis: Visualization and bibliometric analysis;Heliyon;2024-06

2. Does combining adalimumab with methotrexate improve outcomes in psoriasis? Results from 3‐year follow‐up data;Journal of the European Academy of Dermatology and Venereology;2023-08-25

3. Adalimumab combined with methotrexate versus adalimumab monotherapy in psoriasis: Three‐year follow‐up data of a single‐blind randomized controlled trial;Journal of the European Academy of Dermatology and Venereology;2023-04-17

4. A novel hyaluronic acid-based dissolving microneedle patch loaded with ginsenoside Rg3 liposome for effectively alleviate psoriasis;Materials & Design;2022-12

5. Adalimumab with Methotrexate vs. Adalimumab Monotherapy in Psoriasis: First-Year Results of a Single-Blind Randomized Controlled Trial;Journal of Investigative Dermatology;2022-09